These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1007281)

  • 41. The effect of orally administered androgens on sperm count and sperm motility.
    Surabote A
    J Med Assoc Thai; 1984 Aug; 67(8):425-8. PubMed ID: 6520566
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of oral Kallikrein treatment on sperm motility in asthenozoospermia.
    Batterink GJ; Kremer J; Jager S
    Int J Androl; 1983 Apr; 6(2):173-9. PubMed ID: 6553021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of kinin system in male fertility.
    Gecse A; Ottlecz A; Telegdy G; Török L
    Adv Biosci; 1978 Jul; 17():15-23. PubMed ID: 755692
    [No Abstract]   [Full Text] [Related]  

  • 44. [Kallidinogenase treatment of fertility disorders in the male].
    Thiel W; Hoell R; Schreiber G; Zapf W
    Dermatol Monatsschr; 1982 Aug; 168(8):542-6. PubMed ID: 6816639
    [No Abstract]   [Full Text] [Related]  

  • 45. Tamoxifen and kallikrein in therapy of oligoasthenozoospermia: results of a randomized study.
    Maier U; Hienert G
    Eur Urol; 1990; 17(3):223-5. PubMed ID: 2190839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of kallikrein in the treatment of oligozoospermia and asthenozoospermia: a double-blind trial.
    Glezerman M; Lunenfeld E; Potashnik G; Huleihel M; Soffer Y; Segal S
    Fertil Steril; 1993 Dec; 60(6):1052-6. PubMed ID: 8243685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kallikrein therapy of infertile men with varicocele and impaired sperm motility.
    Mićić S; Tulić C; Dotlić R
    Andrologia; 1990; 22(2):179-83. PubMed ID: 2264621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of oligospermic patients with varicocele].
    Shinoda M; Naide Y; Tazaki H
    Hinyokika Kiyo; 1988 Nov; 34(11):1989-94. PubMed ID: 3149452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New perspectives of in vitro kallikrein treatment. II. Study of the hamster ovum penetration test in relation to the kallikrein-kinin system].
    Sterzik K; Schmid U; Strehler E; Rosenbusch B; Schill WB; Lauritzen C
    Zentralbl Gynakol; 1992; 114(7):365-9. PubMed ID: 1509835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of arginine, indomethacin and kallikrein in the treatment of oligoasthenospermia.
    Aydin S; Inci O; Alagöl B
    Int Urol Nephrol; 1995; 27(2):199-202. PubMed ID: 7591579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [On the significance of Solcoseryl on fertility. 1. The effect of Solcoseryl on sperm motility in vitro].
    Mattheus A; Heise H; Hofmann R
    Andrologia; 1980; 12(1):43-8. PubMed ID: 7377552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study.
    Paradisi R; Busacchi P; Seracchioli R; Porcu E; Venturoli S
    Fertil Steril; 2006 Sep; 86(3):728-31. PubMed ID: 16782097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kallikrein and male subfertility. Usefulness of high-unit kallikrein tablets.
    Kamidono S; Hazama M; Matsumoto O; Takada KI; Tomioka O; Ishigami J
    Andrologia; 1981; 13(2):108-20. PubMed ID: 6910373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of semen quality following kallikrein treatment.
    Homonnai ZT; Shilon M; Paz G
    Gynecol Obstet Invest; 1978; 9(2-3):132-8. PubMed ID: 367906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Basic principles of drug therapy in andrology. Experiences of 40 years andrologic treatment].
    Schirren C
    Fortschr Med; 1994 May; 112(14):199-202. PubMed ID: 8050761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
    Schill WB; Reiter F; Korting HC; Schweikert HU
    Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of male subfertility with kallikrein.
    Izzo PL; Canale D; Bianchi B; Meschini P; Esposito G; Menchini Fabris GF; Fasani R; Ohnmeiss H
    Andrologia; 1984; 16(2):156-61. PubMed ID: 6377970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of reactive oxygen species produced by spermatozoa and leukocytes on sperm functions in non-leukocytospermic patients.
    Henkel R; Kierspel E; Stalf T; Mehnert C; Menkveld R; Tinneberg HR; Schill WB; Kruger TF
    Fertil Steril; 2005 Mar; 83(3):635-42. PubMed ID: 15749492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of high dose oral Kallikrein treatment in men with idiopathic subfertility: evaluation by means of in vitro penetration test of zona free hamster ova.
    Comhaire F; Vermeulen L
    Int J Androl; 1983 Apr; 6(2):168-72. PubMed ID: 6553020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The influence of medicated serum with root of Crataegus cuneata on human sperm motility parameters in vitro].
    Hu L; Xiong CL
    Zhongguo Zhong Yao Za Zhi; 2006 Feb; 31(4):333-5. PubMed ID: 16706029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.